Anatomic Pathology Market Trends

Growth Drivers

Growing Cancer Cases – Cancer cases are detected through anatomic pathology report. With the rising cases of cancer and need for biopsies to be performed, the market for anatomic pathology is expected to boost in the projected period. For instance, it was observed that approximately 19 million new cancer cases were registered worldwide in 2020.

Upsurge in the Number of Pathologists – According to reports, it was found that, in the United States there were 21â€¯292 active pathologists in June 2019 compared 12â€¯839 anatomical and clinical pathologists in 2017.

Rising Prevalence of Chron’s disease – According to reports, every year 100 to 300 per 100,000 people suffer from Chron’s disease in North America and western Europe.
Growing Number of People Suffering from Kidney Disease –total number of people suffering from kidney disease is 850 million worldwide in 2021.

Challenges

High Expenditure Associated in Developing Anatomic Pathology
Non-availability of Refurbished Anatomic Pathology Equipment
Challenges in Transformation of Pathology Trends

Anatomic Pathology Market: Key Insights

Base Year	2024
Forecast Year	2025-2037
CAGR	8.4%
Base Year Market Size (2024)	USD 38.48 billion
Forecast Year Market Size (2037)	USD 108.01 bllion
Regional Scope	North America (U.S., and Canada) Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific) Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Latin America (Mexico, Argentina, Brazil, Rest of Latin America) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of anatomic pathology is evaluated at USD 41.1 billion.

The anatomic pathology market size was valued at USD 38.48 billion in 2024 and is anticipated to exceed USD 108.01 billion by the end of 2037, registering over 8.4% CAGR during the forecast period i.e., between 2025-2037. Increasing number of laboratory tests as well as biopsies performed along with rising cases of cancer, kidney diseases and others will propel the market growth.

North America industry will hold a share of 38% by 2037, backed by presence of a strong healthcare network in the region.

The major players in the market include PHC Holdings Corporation, Indica Labs, Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sakura Finetek USA, Inc., Cardinal Health, Inc., BioGenex, NeoGenomics Laboratories, Inc., Agilent Technologies, Inc.

Anatomic Pathology Market Trends